Skip to content

Quikstrip One Step Amphetamine Test

by Drial Consultants, Inc. 510(k)

Active United States

510(k) K971218

Overview

The Quikstrip One Step Amphetamine Test is an enzyme immunoassay device used to screen urine for the presence of amphetamine and its metabolites. It is designed to detect drug presence rather than monitor specific drug levels.

This device is regulated as a class II medical device under 21 CFR 862.3100 and has received FDA 510(k) clearance. Clinical considerations and professional judgment should be applied to all test results, especially when preliminary positive results are indicated.

AI-generated from registry data, 22 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK971218 Date30 May 1997ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DKZ
Device Class
Class II
Regulation
21 CFR Part 862.3100
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Other devices from Drial Consultants, Inc.

See all devices from Drial Consultants, Inc. →

Questions

  • What is the primary purpose of the Quikstrip One Step Amphetamine Test?

    This device is intended to screen urine samples for the presence of amphetamine and its metabolites. It is designed to detect the presence of these substances rather than to monitor specific drug levels.

  • How should clinicians interpret the results from this test?

    Clinical considerations and professional judgment should be applied to all test results. This is particularly important when the device indicates a preliminary positive result, as the test is a screening tool.

  • What is the regulatory classification of this device?

    The Quikstrip One Step Amphetamine Test is regulated as a class II medical device under 21 CFR 862.3100 and has received FDA 510(k) clearance.